# UNICEF

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/unicef-company
Canonical HTML page: https://getbiobrief.com/entity/unicef-company

## Recent coverage (1 stories)

### Takeda's QDENGA Cleared in India: No‑Screen Shot Targets 33% Dengue Burden
2026-07-25 04:23:17 · Sentiment: Very Bullish · Impact: 7/10 · Sources: 2

Takeda's QDENGA gains DCGI approval in India, unlocking a market that bears one‑third of global dengue cases. The vaccine's differentiation—no pre‑screening required and broad 4–60 age label—positions it strongly against legacy products like Sanofi's Dengvaxia.
Full story: https://getbiobrief.com/story/takeda-qdenga-dcgi-approval-biotech

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.